Empire Genomics has been grinding it out as a bio-tech start-up in Buffalo for six years. Built on the brains of founder and chief science officer Norma Jean Nowak, the company just released its first genomic test to help determine a personalized treatment for multiple myeloma, a cancer of the blood.
That's fantastic news for people suffering with the disease, and great news for Buffalo's bio-tech industry. As we all learned last month when SmartPill, another local start-up, was sold to a firm from Israel, it's a long and expensive road to launch a successful bio-tech company.
Genomics says it will hire 50 people in the next five years. The company has made bold predictions before. This time it may be able to deliver.
- Grove Potter